{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:02:03Z","timestamp":1782932523551,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jns.2011.09.023","type":"journal-article","created":{"date-parts":[[2011,10,16]],"date-time":"2011-10-16T01:33:08Z","timestamp":1318728788000},"page":"86-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Trends in comorbid sickle cell disease among stroke patients"],"prefix":"10.1016","volume":"313","author":[{"given":"Bruce","family":"Ovbiagele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jns.2011.09.023_bb0005","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archneur.64.11.1567","article-title":"Big strokes in small persons","volume":"64","author":"Adams","year":"2007","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.jns.2011.09.023_bb0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"Adams","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jns.2011.09.023_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.jns.2011.09.023_bb0020","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jns.2011.09.023_bb0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpeds.2010.03.007","article-title":"Transcranial doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease","volume":"157","author":"Enninful-Eghan","year":"2010","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.jns.2011.09.023_bb0030","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/pbc.21430","article-title":"Evaluation of a comprehensive transcranial Doppler screening program for children with sickle cell anemia","volume":"50","author":"McCarville","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.jns.2011.09.023_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0609.2009.01379.x","article-title":"Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease","volume":"84","author":"Mirre","year":"2010","journal-title":"Eur J Haematol"},{"issue":"23","key":"10.1016\/j.jns.2011.09.023_bb0040","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jns.2011.09.023_bb0045","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.jns.2011.09.023_bb0050","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.2010.562","article-title":"Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia","volume":"303","author":"Vichinsky","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2011.09.023_bb0080","article-title":"National sex-specific trends in hospital-based stroke rates","author":"Ovbiagele","year":"2010","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.jns.2011.09.023_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988\u20132000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.jns.2011.09.023_bb0065","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/jama.294.14.1773","article-title":"Trends in serum lipids and lipoproteins of adults, 1960\u20132002","volume":"294","author":"Carroll","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jns.2011.09.023_bb0070","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jama.288.11.1388","article-title":"New evidence for stroke prevention: scientific review","volume":"288","author":"Straus","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jns.2011.09.023_bb0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/blood-2004-02-0636","article-title":"Declining stroke rates in Californian children with sickle cell disease","volume":"104","author":"Fullerton","year":"2004","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.jns.2011.09.023_bb0085","first-page":"769","article-title":"Obesity prevalence among low-income, preschool-aged children \u2014 United States, 1998\u20132008","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11005855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11005855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:43:19Z","timestamp":1758382999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X11005855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":16,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0022510X11005855"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2011.09.023","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in comorbid sickle cell disease among stroke patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2011.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}